TrianglePUBLICATIONS · 19451431
Improved overall survival with oxaliplatin, fluorouracil, and leucovorin as adjuvant treatment in stage II or III colon cancer in the MOSAIC trial.
Open original source → · Download preserved record
Bibliographic metadata only. No full-text article or abstract is reproduced. Absence of a captured notice is not confirmation that a publication is clear of corrections or retractions.
- Journal
- J Clin Oncol
- Publication date
- 2009 Jul 1
- First author
- André T
Publication notices
- absence is not clearance
- true
- has correction metadata
- false
- has expression of concern metadata
- false
- has retraction in link
- false
- pubmed marks article retracted
- false
- pubmed marks retraction notice
- false
- relationships
Authors and identifiers
- name
- André T
- type
- Author
- name
- Boni C
- type
- Author
- name
- Navarro M
- type
- Author
- name
- Tabernero J
- type
- Author
- name
- Hickish T
- type
- Author
- name
- Topham C
- type
- Author
- name
- Bonetti A
- type
- Author
- name
- Clingan P
- type
- Author
- name
- Bridgewater J
- type
- Author
- name
- Rivera F
- type
- Author
- name
- de Gramont A
- type
- Author
Complete bibliographic record and source provenance
- authors
- name
- André T
- type
- Author
- name
- Boni C
- type
- Author
- name
- Navarro M
- type
- Author
- name
- Tabernero J
- type
- Author
- name
- Hickish T
- type
- Author
- name
- Topham C
- type
- Author
- name
- Bonetti A
- type
- Author
- name
- Clingan P
- type
- Author
- name
- Bridgewater J
- type
- Author
- name
- Rivera F
- type
- Author
- name
- de Gramont A
- type
- Author
- bibliography ids
- nci-bib-5e439170758a1353eb7ecf23
- book metadata
- content sha256
- b545fe3e16723fcfd0ebeb71888e24f66e6a7246408396a286fbeaacb30f5e44
- document type
- citation
- dois
- 10.1200/JCO.2008.20.6771
- electronic publication date
- display
- 2009 May 18
- precision
- day
- year
- 2009
- evidence scope
- bibliographic_metadata_only
- id
- pubmed:19451431
- immutable id
- pubmed:19451431@b545fe3e16723fcfd0ebeb71888e24f66e6a7246408396a286fbeaacb30f5e44
- journal
- abbreviation
- J Clin Oncol
- issn electronic
- 1527-7755
- issn print
- 0732-183X
- issue
- 19
- name
- Journal of clinical oncology : official journal of the American Society of Clinical Oncology
- nlm unique id
- 8309333
- pages
- 3109-16
- volume
- 27
- languages
- eng
- notices
- absence is not clearance
- true
- has correction metadata
- false
- has expression of concern metadata
- false
- has retraction in link
- false
- pubmed marks article retracted
- false
- pubmed marks retraction notice
- false
- relationships
- outcomes validated
- false
- pmid
- 19451431
- provenance
- batch id
- 4f803f1a8e7b4f56d2f1
- provider
- NCBI PubMed ESummary
- record sha256
- 953c9a6d2404e7dbf75de1c89f9383c14cb88cfc2f5020994b8c0d6d1e13bbd4
- response sha256
- fddd7745d591ed24e15d20ce21f0a6c14874b8cee29153ff89c9892037c40127
- retrieved at
- 2026-09-09T23:46:26.391289+00:00
- publication date
- display
- 2009 Jul 1
- precision
- day
- year
- 2009
- publication types
- Clinical Trial, Phase III
- Journal Article
- Multicenter Study
- Randomized Controlled Trial
- Research Support, Non-U.S. Gov't
- record status
- PubMed - indexed for MEDLINE
- schema version
- 1.0
- title
- Improved overall survival with oxaliplatin, fluorouracil, and leucovorin as adjuvant treatment in stage II or III colon cancer in the MOSAIC trial.
Preserved source evidence · Independent clinical review pending · Not medical advice